Skip to content
Psilocybin Technology
Menu
  • Home
  • Contact us about Psilocybin Science and Technology

Month: July 2018

depression / psilocybin / research / treatment / Uncategorized / unmet need

Compass Pathways – Access to Synthetic Psilocybin

Compass Pathways Targeting “Patient Access” to Synthetic Psilocybin Compass Pathways is a life sciences company, founded in 2016, to “accelerate patient access to evidence-based innovation in mental health.” According to their …

Recent Posts

  • Pharmaceutical Psilocybin Research
  • Psilocybin Clinical Trials Approved by FDA
  • Magic Mushrooms vs Cannabis – Entourage Effect
  • Magic Mushroom Bluing Reaction – Request for Research Proposals
  • Microdosing – Petranker and Anderson on State of the Art

Recent Comments

  • keith a duesterhoeft on Pharmaceutical Psilocybin Research
  • Staff Scientist on Psilocybin Clinical Trials Approved by FDA
  • Cathy (Kitty) Brochu Nobora on Psilocybin Clinical Trials Approved by FDA
  • Staff Scientist on Psilocybin Clinical Trials Approved by FDA
  • Staff Scientist on Psilocybin Clinical Trials Approved by FDA

Archives

  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • October 2017

Categories

  • aeruginascin
  • anxiety
  • cognitive enhancement
  • decriminalization
  • depression
  • law
  • legalization
  • mass
  • micro dosing
  • molecules vs. mushrooms
  • mushrooms
  • psilocin
  • psilocybin
  • psilocybin chemistry
  • psilocybin derivatives
  • research
  • state of the art
  • treatment
  • Uncategorized
  • unmet need
  • wood lover paralysis

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org
Copyright © 2018 Psilocybin Technology – OnePress theme by FameThemes